Walleye Capital’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-12,380
| Closed | -$10.6K | – | 3094 |
|
|
2023
Q4 | $10.6K | Sell |
12,380
-133,589
| -92% | -$115K | ﹤0.01% | 1840 |
|
|
2023
Q3 | $156K | Sell |
145,969
-100,994
| -41% | -$108K | ﹤0.01% | 1559 |
|
|
2023
Q2 | $640K | Sell |
246,963
-52,238
| -17% | -$135K | ﹤0.01% | 910 |
|
|
2023
Q1 | $1.22M | Buy |
299,201
+74,884
| +33% | +$306K | 0.02% | 682 |
|
|
2022
Q4 | $1.13M | Buy |
224,317
+209,648
| +1,429% | +$1.05M | 0.02% | 670 |
|
|
2022
Q3 | $192K | Buy |
+14,669
| New | +$192K | ﹤0.01% | 1492 |
|
|
2021
Q4 | – | Sell |
-22,368
| Closed | -$470 | – | 2329 |
|
|
2021
Q3 | $470 | Buy |
+22,368
| New | +$470 | 0.01% | 781 |
|